The activity of antithrombin III (AT III) in the blood of 20 patients with renal carcinoma was examined. An increase of AT III activity in comparison with control group was observed. The increase of AT III activity in the blood of the patients with renal carcinoma can be as a result of compensatory mechanism safing these patients before thromboembolic complication. The measurement of AT III in renal carcinoma can be a prognostic symptom of haemorrhagic and thromboembolic complications.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
iii activity
12
blood patients
12
patients renal
12
renal carcinoma
12
activity blood
8
increase iii
8
iii
5
[antithrombin iii
4
activity
4
patients
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!